Meningococcal vaccine recommendations are scheduled to be reviewed in the next 15 months. Potential changes to the meningococcal recommendations may potentially include the elimination of the age 11–12-year-old meningococcal vaccine (MenACWY), or a switch to a “shared clinical decision-making” recommendation at this age. Additional changes potentially under consideration include an adjustment to the age of recommendation for MenB vaccines to be given closer to age 18-19, and a review of the current “shared clinical decision-making” recommendation.
NVIC “Quick Facts” is not a substitute for becoming fully informed about Meningococcal disease, meningitis and the Meningococcal vaccine. NVIC recommends consumers read the more complete information following the “Quick Facts”, as well as the vaccine manufacturer product information inserts, and speak with one or more trusted health care professionals before making a vaccination decision for yourself or your child.
